AstraZeneca to invest $285 mln in Swedish biotech factory
May 18, 2015 at 04:15 AM EDT
LONDON, May 18 (Reuters) - AstraZeneca is investing $285 million to expand biotech drug manufacturing in Sweden as the company bets on the future of high-tech medicine for future growth.
